Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures - Report - DentalSpire

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures

  • By

  • Zhuqin Xiang

  • Yaqi Huang

  • Bokai Yun

  • Dongpeng Li

  • Fengshuo Liu

  • Junliang Liu

  • Nan Xie

  • Zehang Zhuang

  • Jinsong Hou

  • Cheng Wang

  • June 3, 2026

Share

Clinical Report: Assessing Prognostic Factors in Oral Squamous Cell Carcinoma

Overview

This study validates the prognostic significance of tumor budding (TB) and tertiary lymphoid structures (TLS) in oral squamous cell carcinoma (OSCC). The combined TB/TLS index demonstrates superior prognostic ability compared to individual markers, leading to the development of a nomogram for predicting patient outcomes.

Background

Oral squamous cell carcinoma (OSCC) is a major subtype of head and neck malignancies, with significant global incidence and mortality rates. The current prognosis for OSCC patients remains suboptimal, necessitating improved prognostic tools. Understanding the roles of TB and TLS within the tumor microenvironment can enhance prognostic predictions and treatment strategies.

Data Highlights

{'format': 'Ensure the table is properly formatted and integrated into the report.'}

Key Findings

  • High-grade tumor budding (TB) is associated with poor survival outcomes in OSCC patients.
  • High-maturation tertiary lymphoid structures (TLS) correlate with improved survival rates.
  • The TB/TLS index provides better prognostic discrimination than either marker alone.
  • A nomogram incorporating the TB/TLS index shows reliable predictive performance.
  • External validation of the nomogram indicates moderate predictive capability despite cohort differences.

Clinical Implications

The integration of TB and TLS assessments can enhance prognostic accuracy for OSCC patients, guiding treatment decisions. Clinicians should consider the TB/TLS index when evaluating patient prognosis and tailoring therapeutic strategies.

Conclusion

This study underscores the importance of combining tumor budding and tertiary lymphoid structures in prognostic assessments for OSCC. The developed nomogram may serve as a valuable tool for predicting patient outcomes.

Related Resources & Content

  1. The Impact of Tumor Budding and Tumor-Infiltrating Lymphocytes on Adjuvant Chemotherapy Outcomes in Stage II and III Colon Cancer, Springer, 2021 -- Title
  2. Evaluating the Prognostic Significance of Tumor Stroma Ratio and Tumor Budding in Stage II Colon Cancer: A Nationwide Population-Based Analysis, Springer, 2018 -- Title
  3. Tertiary lymphoid structures in breast cancer: formation, immune functions and clinical implications, Frontiers in Immunology, 2026 -- Title
  4. Tumor Budding and Poor Prognosis in Oral Cancer: A Systematic Review and Meta-Analysis, PMC -- Title
  5. The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review, PMC -- Title
  6. The Role of Programmed Death Ligand 1 (PD-L1) in Colorectal Cancer and Its Relationship with Tumor-Infiltrating Lymphocytes (TILs) and Budding as Opposing Forces in Tumor Dynamics
  7. NCCN Head and Neck Cancers Guidelines Version 1.2026
  8. Tumor Budding and Poor Prognosis in Oral Cancer: A Systematic Review and Meta-Analysis - PMC
  9. The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review - PMC

Original Source(s)

Related Content